Regulation of sex steroid formation by interleukin-4 and interleukin-6 in breast cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 65, Issue 1-6, 1998, Pages 151-162

  Turgeon, Carl ^a   Gingras, Sébastien ^a   Carrière, Marie Claude ^a   Blais, Yves ^a   Labrie, Fernand ^a   Simard, Jacques ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANDROSTENEDIONE; CYTOKINE; INTERLEUKIN 4; INTERLEUKIN 6; PRASTERONE; SEX HORMONE; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE;

ADRENAL GLAND; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; SEXUAL MATURATION; STEROIDOGENESIS;

17-HYDROXYSTEROID DEHYDROGENASES; 3-HYDROXYSTEROID DEHYDROGENASES; BREAST NEOPLASMS; CELL DIVISION; CELL-FREE SYSTEM; DRUG INTERACTIONS; ENZYME INDUCTION; ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; HUMANS; HYDROXYSTEROID DEHYDROGENASES; INTERLEUKIN-4; INTERLEUKIN-6; OXIDATION-REDUCTION; STEROIDS; TUMOR CELLS, CULTURED;

EID: 0032053234     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(98)00031-4     Document Type: Conference Paper

References (74)

1. Davidson N. E., Lippman M. E. The role of estrogens in growth regulation of breast cancer. Oncogenesis. 1:1989;89-104.
2. King R. G. B. A discussion of the roles of estrogen and progestin in human mammary carcinogenesis. J. Steroid Biochem. Mol. Biol. 39:1991;811-818.
3. Bernstein L., Ross R. K. Endogenous hormones and breast cancer risk. Epidemiol. Rev. 15:1993;48-65.
4. Bonney R. C., Reed M. J., Davidson K., Beranek P. A., James V. H. T. The relationship between 17β-HSD activity and oestrogen concentrations in human breast tumours and in normal breast tissue. Clin. Endocrinol. 19:1983;727-739.
5. Van Landedgem A. A. J., Poortman J., Nabuurs M., Thijssen J. H. H. Endogenous concentratrions and subcellular distribution of estrogens in normal and malignant human breast cancer tissues. Cancer Res. 45:1985;2900-2906.
6. Vermeulen A., Deslypere J. P., Paridaens R., Leclerq G., Roy F., Henson J. C. Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentration in cancerous and normal glandular breast tissue in postmenopausal women. Eur. J. Cancer. 22:1986;515-525.
7. Recchione C., Ventrurelli E., Manzari A., Cavalleri A., Martinetti A., Secreto G. Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissue. J. Steroid Biochem. 52:1995;541-546.
8. 3H -estradiol by normal breast and breast tumour tissues in post-menopausal women Int. J. Cancer. 38:1986;193-196.
9. 5-steroids in ZR-75-1 human breast cancer cell line. Cancer Res. 46:1986;4933-4937.
10. Pasqualini J. R., Gelly C., Nguyen B. L., Vella C. Importance of estrogen sulfates in breast cancer. J. Steroid. Biochem. 34:1989;155-163.
11. Adams E. F., Coldham N. G., James V. H. T. Steroidal regulation of oestradiol-17β-dehydrogenase activity of the human breast cancer cell line MCF-7. J. Endocrinol. 118:1988;149-154.
12. Poutanen M., Isomaa V., Kainulainen K., Vihko R. Progestin induction of 17β-hydroxysteroid dehydrogenase enzyme protein in the T-47D human breast cancer cell line. Int. J. Cancer. 46:1990;897-901.
13. Couture P., Thériault C., Simard J., Labrie F. Androgen receptor-mediated stimulation of 17β-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Endocrinology. 132:1993;179-185.
14. Labrie F., Luu-The V., Lin S.-X., Labrie C., Simard J., Breton R., Bélanger A. The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology. Steroids. 62:1997;148-158.
15. Martel C., Rhéaume E., Takahashi M., Trudel C., Couet J., Luu-The V., Simard J., Labrie F. Distribution of 17β-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues. J. Steroid. Biochem. Mol. Biol. 41:1992;597-603.
16. Tait G. H., Newton C. J., Reed M. J., James V. H. T. Multiple forms of 17β-hydroxysteroid dehydrogenase in human breast tissue. J. Mol. Endocrinol. 2:1989;71-80.
17. MacIndoe J. H. Dehydroepiandrosterone and estrone 17-ketosteroid reductases in MCF-7 human breast cancer cells. Breast Cancer Res. Treat. 16:1990;261-272.
18. Poutanen M., Montcharmont B., Vihko R. 17β-hydroxysteroid dehydrogenase gene expression in human breast cancer cells: regulation of expression by a progestin. Cancer Res. 52:1992;290-294.
19. Peltoketo H., Isomaa V., Mäentausta O., Vihko R. Complete amino acid sequence of human placental 17β-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Lett. 239:1988;73-77.
20. Luu-The V., Labrie C., Zhao H. F., Couet J., Lachance Y., Simard J., Leblanc G., Côté G., Bérubé D., Gagné R., Labrie F. Characterization of cDNAs for human estradiol 17β-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5′ termini in human placenta. Mol. Endocrinol. 3:1989;1301-1309.
21. Lin S.-H., Yang F., Jin J.-Z., Breton R., Zhu D.-W., Luu-The V., Labrie F. Subunit identity of the dimeric 17β-hydroxysteroid dehydrogenase from human placenta. J. Biol. Chem. 267:1992;16182-16187.
22. Luu-The V., Labrie C., Simard J., Lachance Y., Zhao H.-F., Couet J., Leblanc G., Labrie F. Structure of two in tandem human 17β-hydroxysteroid dehydrogenase genes. Mol. Endocrinol. 4:1990;268-275.
23. Rommens J. M., Durocher F., McArthur J., Tonin P., Leblanc J.-F., Allen T., Samson C., Ferri L., Narod S., Morgan K., Simard J. Generation of a transcription map at the HSD17B locus centromeric to BRCA1 at 17q21. Genomics. 28:1995;530-542.
24. Ghosh D., Pletnev V., Zhu D.-W., Wawrzak Z., Duax W., Pangborn W., Labrie F., Lin S.-X. Structure of human estrogenic 17β-hydroxysteroid dehydrogenase complexed with 17β-estradiol at 2.20 Å resolution. Structure. 3:1995;503-513.
25. Zhu D.-W., Azzi Z., Rehse P., Lin S.-X. The cristallogenesis of a human estradiol dehydrogenase complex. J. Crystal Growth. 168:1996;272-276.
26. Azzi Z., Rehse P., Zhu D.-W., Campbell R. L., Labrie F., Lin S.-X. Crystal structure of human estrogenic 17β-hydroxysteroid dehydrogenase complexed with 17β-estradiol at 2.3 Å resolution. Nature Struct. Biol. 3:1996;665-668.
27. + identifies two principal targets for design of inhibitors. Structure. 4:1996;905-915.
28. Sasano H., Frost A. R., Saitoh R., Harada N., Poutanen M., Vihko R., Bulun S. E., Silverberg S. G., Nagura H. Aromatase and 17β-hydroxysteroid dehydrogenase type 1 in human breast carcinoma. J. Clin. Endo. Meta. 81:1996;4042-4046.
29. Piao Y.-S., Peltoketo H., Jouppila A., Vihko J. Retinoic acids increase 17β-hydroxysteroid dehydrogenase type 1 expression in JEG-3 and T47D cells, but the stimulation is potentiated by epidermal growth factor, 12-O-tetradecanoyphorbol-13-acetate, and cyclic adenosine 3′,5′-monophosphate only in JEG-3 cells. Endocrinology. 138:1997;898-904.
30. Peltoketo H., Isomaa V., Poutanen M., Vihko R. Expression and regulation of 17β-hydroxysteroid dehydrogenase type. J. Endocrinol. 50:1996;S21-S30.
31. Wu L., Eisntein M., Geissler W. M., Chan H. K., Elliston K. O., Anderson S. Expression cloning and characterization of human 17β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme 20α-hydroxysteroid dehydrogenase activity. J. Biol. Chem. 268:1993;12964-12969.
32. Labrie Y., Durocher F., Lachance Y., Turgeon C., Simard J., Labrie C., Labrie F. The human type II 17β-hydroxysteroid dehydrogenase gene encodes two alternalively spliced mRNA species. DNA Cell Biol. 14:1995;849-861.
33. Durocher F., Morissette J., Labrie Y., Labrie C., Simard J. Mapping of the HSD17B2 gene encoding type II 17β-hydroxysteroid dehydrogenase close to D16S422 on chromosome 16q24.1-q24.2. Genomics. 24:1995;724-726.
34. Geissler W. M., Davis D. L., Wu L., Bradshaw K. D., Patel S., Mendonca B. B., Elliston K. O., Wilson J. D., Russell D. W., Andersson S. Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3. Nature Genetics. 7:1994;34-39.
35. Adamski J., Normand T., Iffnder F., Monte D., Begue A., Stehelin D., Jungslut P. W., de Launoit Y. Molecular cloning of a novel widely expressed human 80 kDa 17β-hydroxysteroid dehydrogenase IV. Biochem. J. 311:1995;437-443.
36. Carstensen J. F., Tesdorpf J. G., Kaufmann M., Markus M. M., Husen B., Leenders F., Jakob F., de Launoit Y., Adamski J. Characterization of 17β-hydroxysteroid dehydrogenase IV. J. Endocrinol. 50:1996;S3-S12.
37. Labrie F. Intracrinology. Mol. Cell. Endocrinol. 78:1991;C113-C118.
38. Simard J., Durocher F., Mébarki F., Turgeon C., Sanchez R., Labrie Y., Couet J., Trudel C., Rhéaume E., Morel Y., Luu-The V., Labrie F. Molecular biology and genetics of the 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase gene family. J. Endocrinol. 50:1996;S189-S207.
39. Martel C., Melner M. H., Gagné D., Simard J., Labrie F. Widespread tissue distribution of steroid sulfatase, 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase (3β-HSD), 17β-HSD, 5α-reductase and aromatase activities in the rhesus monkey. Mol. Cell. Endocrinol. 104:1994;103-111.
40. Rhéaume E., Lachance Y., Zhao H.-F., Breton N., Dumont M., de Launoit Y., Trudel C., Luu-The V., Simard J., Labrie F. Structure and expression of a new complementary DNA encoding the almost exclusive 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase in human adrenal and gonads. Mol. Endocrinol. 5:1991;1147-1157.
41. Adams E. F., Newton C. J., Tait G. H., Braunsberg H., Reed M. J., James V. H. T. Paracrine influence of human breast stromal fibroblasts on breast epithelial cells: secretion of a polypeptide which stimulates reductive 17β-oestradiol dehydrogenase activity. Int. J. Cancer. 42:1988;119-122.
42. Adams E. F., Newton C. J., Braunsberg H., Shaikh N., Ghilchik M., James V. H. T. Effects of human breast fibroblasts on growth and 17β-oestradiol dehydrogenase activity in MCF-7 cells in culture. Breast Cancer Res. Treat. 11:1988;165-172.
43. Dickson, R. B. and Lippman, M. E., Autocrine and paracrine growth factors in the normal and neoplastic breast. In Diseases of the Breast, ed. J. R. Harris, M. E. Lippman, M. Morrow and S. Hellman. Lippincott-Raven Publiskers, Philadelphia, 1996, pp. 272-292.
44. Kelly P. M. A., Davison R. S., Bliss E., McGee J. O. D. Macrophages in human breast disease: a quantitative immunohistochemical study. Br. J. Cancer. 57:1988;174-177.
45. Whitford P., Mallon E. A., George W. D., Campbell A. M. Flow cytometric analysis of tumor infiltrating lymphocytes in breast cancer. Br. J. Cancer. 2:1990;971-975.
46. Lorenzen J., Lewis C. E., McCraken D., Horak E., Greenall M. Human Tumor-associated NK cells secrete increased amounts of interferon-γ and interlukin-4. Br. J. Cancer. 64:1991;457-462.
47. Tamm I., Cardinale I., Krueger J., Murphy J. S., May L. T., Sehgal P. B. Interleukin-6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J. Exp. Med. 170:1989;1649-1669.
48. Tamm I., Cardinale I., Murphy J. S. Decreased adherence of interleukin-6-treated breast carcinoma cells can lead to separation from neighbors after mitosis. Proc. Natl. Acad. Sci. U.S.A. 88:1991;4414-4418.
49. Danforth D. N., Sgagias M. K. Interleukin-1α and interleukin-6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro. Cancer Res. 53:1993;1538-1545.
50. Paciotti G. F., Tamarkin L. Interleukin-1 directly regulates hormone-dependent human breast cancer cell proliferation in vitro. Mol. Endocrinol. 2:1988;459-464.
51. Chen L., Mory Y., Zilberstein A. Growth inhibition of human breast carcinoma and leukemia/lymphomia cell lines by recombinant interferon-γ Proc. Natl. Acad. Sci. U.S.A. 85:1988;8037-8041.
52. Danforth D. N., Sgagias M. K. Interleukin-1α blocks estradiol-stimulated growth and down-regulates the estrogen receptor in MCF-7 breast cancer cells in vitro. Cancer Res. 51:1991;1488-1493.
53. Blais Y., Sugimoto K., Carrière M. C., Haagensen D. E., Labrie F., Simard J. Potent stimulatory effect of interleukin-1α on apolipoprotein D and gross cystic disease fluid protein-15 expression in human breast cancer cells. Int. J. Cancer. 59:1994;400-407.
54. Blais Y., Sugimoto K., Carriere M. C., Haagensen D. E., Labrie F., Simard J. Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin-1α on apolipoprotein D and GCDFP-15 expression in human breast cancer cells. Int. J. Cancer. 62:1995;732-737.
55. Blais Y., Gingras S., Haagensen D. E., Labrie F., Simard J. Interleukin-4 and interleukin-13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells. Mol. Cell. Endocrinol. 121:1996;11-18.
56. Douglas A. M., Goss G. A., Sutherland R. L., Hilton D. J., Bernst M. C., Nicola N. A., Begley C. G. Expression and function of the cytokine receptor superfamily on breast cancer. Oncogene. 14:1997;661-669.
57. Simard J., Dauvois S., Haagensen D. E., Lévesque C., Mérand Y., Labrie F. Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer. Endocrinology. 126:1990;3223-3231.
58. Adams E. F., Rafferty B., White M. C. Interleukin-6 is secreted by breast fibroblasts and stimulates 17β-oestradiol oxidoreductase activity of MCF-7 cells: possible paracrine regulation of breast 17β-oestradiol levels. Int. J. Cancer. 49:1991;118-121.
59. Duncan L. J., Coldham N. G., Reed M. J. The interaction of cytokines in regulating oestradiol 17β-hydroxysteroid dehydrogenase activity in MCF-7 cells. J. Steroid. Biochem. Mol. Biol. 49:1994;63-68.
60. Rodbard D. Apparent positive cooperative effect in cyclic AMP and corticosteroid production by isolated adrenal cells in response to ACTH analogs. Endocrinology. 94:1974;1427-1437.
61. Obiri N. I., Siegel J. P., Varricchio F., Puri R. K. Expression of high affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells. Clin. Exp. Immnunol. 95:1994;148-155.
62. Yamasaki K., Taga T., Hirata Y., Yawata H., Kawanishi Y., Seed B., Taniguchi T., Hirano T., Kishimoto Y. Cloning and expression of the human interleukin-6 (BSF-2/IFNb2) receptor. Science. 241:1988;825-828.
63. Wilks, A. F. and Oates, A., The JAK/STAT pathway. In Cell Signalling, Cancer Surveys, Vol. 27, ed. P. Parker and T. Pawson. Cold Spring Harbor Laboratory Press, New York, 1996, pp. 139-163.
64. Kishimoto T., Akira S., Narazaki M., Taga T. Interleukin-6 family of cytokines and gp130. Blood. 86:1995;1243-1254.
65. Kaklamanis L., Koukourakis M. I., Leek R., Giatromanolaki A., Ritter M., Whitehouse R., Gatter K. C., Harris A. L. Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significance. Br. J. Cancer. 74:1996;1627-1631.
66. Al-Tubuly A. A., Luqmani Y. A., Shousha S., Melcher D., Ritter M. A. Differential expression of gp200-MR6 molecule in benign hyperplasia and down-regulation in invasive carcinoma of the breast. Br. J. Cancer. 74:1996;1005-1011.
67. Reed M. J., Purohit A. Breast cancer and the role of cytokines in regulating estrogen synthesis: an emerging hypothesis. Endocrine Rev. 18:1997;701-715.
68. Ihle J. N. STATs: Signal transducers and activators of transcription. Cell. 84:1996;331-334.
69. Leaman D. W., Leung S., Li X., Stark G. R. Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J. 10:1996;1578-1588.
70. Watson C. J., Miller W. R. Elevated levels of members of the STAT family of transcrition factors in breast carcinoma nuclear extracts. Br. J. Cancer. 71:1995;840-844.
71. Toi M., Bicknell R., Harris A. L. Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res. 52:1992;275-279.
72. Quelle F. W., Shimoda K., Thierfelder W., Fischer C., Kim A., Ruben S. M., Cleveland J. L., Peirce J. H., Keegan A. D., Nelms K., Paul W. E. P., Ihle J. N. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-13 but are not required for mitogenesis. Mol. Cell. Biol. 15:1995;3336-3343.
73. Labrie F., Simard J., de Launoit Y., Poulin R., Thériault C., Dumont M., Dauvois S., Martel C., Li S. Androgens and breast cancer. Cancer Detect. Prevent. 16:1992;31-38.
74. Couillard, S., Labrie, C., Belanger, A., Candas, B., Pouliot, F. and Labrie, F., Inhibitory effect of dehydroepiandrosterone and of the novel antiestrogen EM-800 on the growth of human ZR-75-1 breast cancer xenograts in nude mice. J. Natl. Cancer. Inst., 1998 (in press).